Roche’s (OTCQX:RHHBY) Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The planned Holly Springs facility, spanning 700,000 ...

Roche and Genentech Announce New North Carolina Manufacturing Facility Future 700,000 sq. ft. facility in Holly Springs, NC, will support pharma division’s metabolic medicines portfolio ...

(RTTNews) - Roche Holding AG (RHHBY), Monday announced plans to invest over $700 million in a new state-of-the-art drug manufacturing facility in Holly Springs, North Carolina, creating more than ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million in a new 700,000 square ...

Genentech plans a $700 million biotech facility in Holly Springs, NC, creating 420 high-paying jobs. State and local incentives total $46 million.

"840 life sciences companies do business in North Carolina, and an additional 2,500 companies serve the industry and its unique needs. More than 210,000 jobs are tied to this ecosystem," said Stein.

witzerland-based biotechnology giant Roche plans to invest $50 billion in the United States in the next five years. These investments will further strengthen Roche’s U.S. footprint with 13 ...